In-stent restenosis after revascularization of myocardium with drug-eluting stents is accompanied by elevated level of blood plasma eosinophil cationic protein.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Canadian Journal of Physiology and Pharmacology

• Publication date

  2011-07-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1139/y11-038PMID 21751895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eosinophils and risk stratification of patients treated by coronary stenting.

  2012cited by this paper
• Eosinophil cationic protein and clinical outcome after bare metal stent implantation.

  2011cited by this paper
• The evolving role of inflammatory biomarkers in risk assessment after stent implantation.

  2010cited by this paper
• Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents.

  2009cited by this paper
• Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents.

  2009cited by this paper
• Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule‐derived cytokines and other proteins

  2008cited by this paper
• Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

  2006cited by this paper
• Different inflammatory response and oxidative stress in neointimal hyperplasia after balloon angioplasty and stent implantation in cholesterol-fed rabbits.

  2006cited by this paper
• Eosinophils Can Function as Antigen-Presenting Cells To Induce Primary and Secondary Immune Responses to Strongyloides stercoralis

  2006cited by this paper
• In stent restenosis: bane of the stent era

  2006cited by this paper
• Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting Stents

  2005cited by this paper
• Eosinophil-fibroblast interactions induce fibroblast IL-6 secretion and extracellular matrix gene expression: implications in fibrogenesis.

  2005cited by this paper
• Molecular Basis of Restenosis and Drug-Eluting Stents

  2005cited by this paper
• Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function?

  2005cited by this paper
• From bench to bedside

  2005cited by this paper
• Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious?

  2004cited by this paper
• Granulation tissue with eosinophil infiltration in the restenotic lesion after coronary stent implantation.

  2004cited by this paper
• Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in Primates: Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted

  2002cited by this paper
• Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted Targeting CCR 2 or CD 18 Inhibits Experimental In-Stent Restenosis in Primates :

  2002cited by this paper
• Bench to bedside: the development of rapamycin and its application to stent restenosis.

  2001cited by this paper
• Role of IL-5 in Innate and Adaptive Immunity to Larval Strongyloides stercoralis in Mice1

  2000cited by this paper
• Neutrophil, Not Macrophage, Infiltration Precedes Neointimal Thickening in Balloon-Injured Arteries

  2000cited by this paper
• Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).

  1999cited by this paper
• Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease

  1999cited by this paper
• Human Eosinophils Regulate Human Lung- and Skin-Derived Fibroblast Properties in vitro: A Role for Transforming Growth Factor β (TGF-β)

  1999cited by this paper
• MOLECULES IN FOCUS. EOSINOPHIL CATIONIC PROTEIN (ECP)

  1998cited by this paper
• Blood sample processing effect on eosinophil cationic protein concentration.

  1997cited by this paper
• Mechanisms of action of new immunosuppressive drugs.

  1995cited by this paper
• Mechanisms of Action of New Immunosuppressive Drugs

  1995cited by this paper
• 163 血清中 Eosinophil Cationic Protein (ECP) 濃度と小児気管支喘息2年後の転帰との関連について

  1993cited by this paper
• Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression.

  1993cited by this paper
• Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

  1992cited by this paper
• Eosinophils stimulate fibroblast DNA synthesis.

  1987cited by this paper
• Cellular localization and quantitation of tritiated antigen in mouse lymph nodes during early primary immune response.

  1966cited by this paper
• Studies in Experimental Eosinophilia

  1964cited by this paper
• STUDIES IN EXPERIMENTAL EOSINOPHILIA

  1964cited by this paper
• Studies in Experimental Eosinophilia

  1961cited by this paper

• Hypersensitivity and in-stent restenosis in coronary stent materials

  2022cites this paper
• Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes

  2021cites this paper
• Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease

  2018cites this paper
• The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting

  2017cites this paper
• Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty

  2016cites this paper
• Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study.

  2014cites this paper
• Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein.

  2014cites this paper
• Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up

  2013cites this paper
• Eosinophils and risk stratification of patients treated by coronary stenting.

  2012cites this paper